A novel isoquinoline derivative anticancer agent and its targeted delivery to tumor cells using transferrin-conjugated liposomes

Xuewei Yang; Shuang Yang; Hongyu Chai; Zhaogang Yang; Robert J. Lee; Weiwei Liao; Lesheng Teng

doi:10.1371/journal.pone.0136649

A novel isoquinoline derivative anticancer agent and its targeted delivery to tumor cells using transferrin-conjugated liposomes

Xuewei Yang, Shuang Yang, Hongyu Chai, Zhaogang Yang, Robert J. Lee, Weiwei Liao, Lesheng Teng

Research output: Contribution to journal › Article › peer-review

61 Scopus citations

Abstract

We have screened 11 isoquinoline derivatives and α-methylene-?-butyrolactones using the 3-(4,5-dimethylthi-azol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cytotoxicity assay in HeLa and HEK-293T cells. Compound 2 was identified as potential anticancer agent. To further improve its therapeutic potential, this agent was incorporated into transferrin (Tf)-conjugated liposomes (LPs) for targeted delivery to tumor cells. We have demonstrated Tf-LP-Compound 2 have superior antitumor activity compared to non-targeted controls and the free drug. These data show Tf-LP-Compound 2 to be a promising agent that warrants further evaluation.

Original language	English (US)
Article number	e0136649.
Journal	PloS one
Volume	10
Issue number	8
DOIs	https://doi.org/10.1371/journal.pone.0136649
State	Published - Aug 26 2015
Externally published	Yes

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)
Agricultural and Biological Sciences(all)
General

Access to Document

10.1371/journal.pone.0136649

Cite this

@article{3af000c417e04340acd16e161e08fb22,

title = "A novel isoquinoline derivative anticancer agent and its targeted delivery to tumor cells using transferrin-conjugated liposomes",

abstract = "We have screened 11 isoquinoline derivatives and α-methylene-?-butyrolactones using the 3-(4,5-dimethylthi-azol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cytotoxicity assay in HeLa and HEK-293T cells. Compound 2 was identified as potential anticancer agent. To further improve its therapeutic potential, this agent was incorporated into transferrin (Tf)-conjugated liposomes (LPs) for targeted delivery to tumor cells. We have demonstrated Tf-LP-Compound 2 have superior antitumor activity compared to non-targeted controls and the free drug. These data show Tf-LP-Compound 2 to be a promising agent that warrants further evaluation.",

author = "Xuewei Yang and Shuang Yang and Hongyu Chai and Zhaogang Yang and Lee, {Robert J.} and Weiwei Liao and Lesheng Teng",

note = "Publisher Copyright: {\textcopyright} 2015 Yang et al.",

year = "2015",

month = aug,

day = "26",

doi = "10.1371/journal.pone.0136649",

language = "English (US)",

volume = "10",

journal = "PLoS One",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "8",

}

TY - JOUR

T1 - A novel isoquinoline derivative anticancer agent and its targeted delivery to tumor cells using transferrin-conjugated liposomes

AU - Yang, Xuewei

AU - Yang, Shuang

AU - Chai, Hongyu

AU - Yang, Zhaogang

AU - Lee, Robert J.

AU - Liao, Weiwei

AU - Teng, Lesheng

PY - 2015/8/26

Y1 - 2015/8/26

N2 - We have screened 11 isoquinoline derivatives and α-methylene-?-butyrolactones using the 3-(4,5-dimethylthi-azol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cytotoxicity assay in HeLa and HEK-293T cells. Compound 2 was identified as potential anticancer agent. To further improve its therapeutic potential, this agent was incorporated into transferrin (Tf)-conjugated liposomes (LPs) for targeted delivery to tumor cells. We have demonstrated Tf-LP-Compound 2 have superior antitumor activity compared to non-targeted controls and the free drug. These data show Tf-LP-Compound 2 to be a promising agent that warrants further evaluation.

AB - We have screened 11 isoquinoline derivatives and α-methylene-?-butyrolactones using the 3-(4,5-dimethylthi-azol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cytotoxicity assay in HeLa and HEK-293T cells. Compound 2 was identified as potential anticancer agent. To further improve its therapeutic potential, this agent was incorporated into transferrin (Tf)-conjugated liposomes (LPs) for targeted delivery to tumor cells. We have demonstrated Tf-LP-Compound 2 have superior antitumor activity compared to non-targeted controls and the free drug. These data show Tf-LP-Compound 2 to be a promising agent that warrants further evaluation.

UR - http://www.scopus.com/inward/record.url?scp=84943328017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943328017&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0136649

DO - 10.1371/journal.pone.0136649

M3 - Article

C2 - 26309138

AN - SCOPUS:84943328017

SN - 1932-6203

VL - 10

JO - PLoS One

JF - PLoS One

IS - 8

M1 - e0136649.

ER -

A novel isoquinoline derivative anticancer agent and its targeted delivery to tumor cells using transferrin-conjugated liposomes

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this